A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
10/2011
10/12/2011	EP2374876A2 Therapy for alpha-galactosidase a deficiency
10/12/2011	EP2374871A1 Pluripotent stem cells, method for preparation thereof and uses thereof
10/12/2011	EP2374814A2 Peptides that ellicit T cellular immunity
10/12/2011	EP1487482B1 Dna vaccine against proliferating endothelial cells and methods of use thereof
10/12/2011	EP1191096B1 Ovel protein and dna thereof
10/12/2011	CN102215873A Dendritic cell modulatory molecule
10/12/2011	CN102215870A Diagnosis method and therapeutic method for cancer
10/12/2011	CN102212559A Recombinant HSV (Herpes Simplex Virus) amplicon vector and application thereof
10/12/2011	CN102212558A Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses therefor
10/12/2011	CN102212557A Recombinant vector for preparing medicament for treating atherosclerosis and recombinant cell
10/12/2011	CN102212556A Recombinant adeno-associated virus vector of tumour-targeted double genes
10/12/2011	CN102212555A Method for constructing pSU6-miR-122 vector expressing miR-122 and application of pSU6-miR-122 vector
10/12/2011	CN102212520A Small interfering RNA (siRNA) sequence for specifically silencing chicken Marek's disease virus gI and gE genes and vectors and application thereof
10/12/2011	CN102212133A Fab segment of human-source human immunodeficiency virus (HIV) antibody and coded gene and application thereof
10/12/2011	CN102212108A Determination and application of human RACK1 (receptor for activated C kinase 1) epitope interacting with MKK7 (mitogen-activated protein kinase kinase 7)
10/12/2011	CN102210875A LAMP-oriented BAP31 vaccine vector capable of inducing immune response and application thereof
10/12/2011	CN102210874A Preparation method of HIV (Human Immunodeficiency Virus) recombinant subtype DNA (Deoxyribonucleic Acid) vaccine
10/12/2011	CN102210873A Application of C10orf116 genes in preparing medicament for improving insulin sensitivity of adipose tissue
10/12/2011	CN102210867A pH reversible response mesoporous silicon oxide composite medicament-carrying system, preparation method thereof and application thereof
10/12/2011	CN101822845B Genomic medicine for inhabiting lung cancer transfer and pulmonary metastatic tumor
10/12/2011	CN101659954B Recombinant adenovirus expressing mycoplasma hyopneumoniae P102 protein and applications thereof
10/12/2011	CN101586115B Gene coexpression recombinant plasmid and DNA vaccine prepared from same
10/12/2011	CN101225383B RNA interference sequence and recombinant interference plasmid of fucosyl transferase I and IV for suppressing synthesis of LeY carbohydrate antigen
10/12/2011	CN101160139B Therapeutic agent for disease with apoptotic degeneration in eye tissue cell containing PEDF and FGF2
10/11/2011	US8034794 Methods and compositions for acid phosphatase-1 gene inhibition
10/11/2011	US8034791 Activation of Egr-1 promoter by DNA damaging chemotherapeutics
10/11/2011	US8034790 Use of MDA-7 to inhibit pathogenic infectious organisms
10/11/2011	US8034620 Lentiviral packaging cells and uses therefor
10/11/2011	US8034619 Polyamides for nucleic acid delivery
10/11/2011	US8034589 Method of preparing a proliferation-regulated recombinant adenoviral vector efficiently and kit for preparing the same
10/11/2011	US8034349 Peptides that mimic non-human cross-reactive protective epitopes of the group B meningococcal capsular polysaccharide
10/11/2011	US8034331 Method of delivery of nucleic acids to peripheral neurons
10/11/2011	CA2468258C Peptide agonists of prostate-specific antigen, and uses therefor
10/11/2011	CA2447538C Cellular signal-responsive gene transcriptional regulation system
10/11/2011	CA2442993C Nucleic acid and corresponding protein entitled 158p3d2 useful in treatment and detection of cancer
10/11/2011	CA2390472C Anti-inflammatory actions of cytochrome p450 epoxygenase-derived eicosanoids
10/11/2011	CA2341356C Poxvirus with targeted infection specificity
10/06/2011	WO2011123621A2 2' and 5' modified monomers and oligonucleotides
10/06/2011	WO2011123427A2 Treatment of cancer by inhibiting activity or expression of late sv-40 factor
10/06/2011	WO2011122634A1 Prognostic method for pulmonary adenocarcinoma, pulmonary adenocarcinoma detection kit, and pharmaceutical composition for treating pulmonary adenocarcinoma
10/06/2011	WO2011120953A1 Polymers for delivering molecules of interest
10/06/2011	WO2011120332A1 Double-stranded rna molecules with stability in mammalian body fluid, preparation and application thereof
10/06/2011	WO2011094806A8 Diagnostic and prognostic assay for breast cancer
10/06/2011	WO2011071632A3 Modified insm1-promoter for neuroendocrine tumor therapy and diagnostics
10/06/2011	WO2011053660A3 Novel therapeutic rna interference technology targeted to the pdx-1 oncogene in pdx-1 expressing neuroendocrine tumors
10/06/2011	WO2011019815A3 Treatment of adiponectin (adipoq) related diseases by inhibition of natural antisense transcript to an adiponectin (adipoq)
10/06/2011	WO2010042281A9 Antisense oligonucleotides directed against connective tissue growth factor and uses thereof
10/06/2011	US20110247087 Regulation of endogenous gene expression in cells using zinc finger proteins
10/06/2011	US20110245772 Focal calcium channel modulation
10/06/2011	US20110245471 NUCLEAR FACTOR kappaB INDUCING FACTOR
10/06/2011	US20110245331 Inhibitors of epoxide hydrolases for the treatment of hypertension
10/06/2011	US20110245320 Nuclease resistant double-stranded ribonucleic acid
10/06/2011	US20110245318 Rna sequence-specific mediators of rna interference
10/06/2011	US20110244576 Herpes Simplex Virus Complex
10/06/2011	US20110244568 Rna sequence-specific mediators of rna interference
10/06/2011	US20110244561 siRNA-MEDIATED GENE SILENCING
10/06/2011	US20110244446 Rna sequence-specific mediators of rna interference
10/06/2011	US20110244026 Delivery of mrna for the augmentation of proteins and enzymes in human genetic diseases
10/06/2011	US20110243968 Therapeutic applications of p53 isoforms in regenerative medicine, aging and cancer
10/06/2011	US20110243912 Growth Factor Binding Constructs Materials and Methods
10/06/2011	US20110243904 Rna interference target for treating aids
10/06/2011	US20110243901 Compositions and Methods for the Treatment of Lysosomal Storage Disorders
10/06/2011	US20110243897 Modification of nucleic acid vectors with polymers comprising charged quaternary amino groups
10/06/2011	US20110243854 Methods and systems for identifying modulators of longevity
10/06/2011	US20110243842 Mammalian receptor proteins; related reagents and methods
10/06/2011	CA2795145A1 Treatment of colony-stimulating factor 3 (csf3) related diseases by inhibition of natural antisense transcript to csf3
10/06/2011	CA2794392A1 Transcription factor decoys
10/05/2011	EP2371966A1 Recombinant lentiviral vector for expression of a Flaviviridae protein and applications thereof as a vaccine
10/05/2011	EP2371959A2 Treatment of neurodegenerative disease through intracranial delivery of siRNA
10/05/2011	EP2371956A2 Immunostimulatory properties of oligonucleotide-based compounds comprising modified immunostimulatory dinucleotides
10/05/2011	EP2371955A1 Integrase cofactor
10/05/2011	EP2371954A1 Compositions and methods for short interfering nucleic acid inhibition of NAv1.8
10/05/2011	EP2371861A1 Monoclonal antibodies against extracellular loops of C5aR
10/05/2011	EP2371835A1 Inhibition of syk kinase expression
10/05/2011	EP2371834A1 Stabilized immunomodulatory oligonucleotides
10/05/2011	EP2370579A2 Treatment of erythropoietin (epo) related diseases by inhibition of natural antisense transcript to epo
10/05/2011	EP2370108A1 Modification of nucleic acid vectors with polymers comprising charged quaternary amino groups
10/05/2011	EP1948245B1 Compositions and their uses for gene therapy of bone conditions
10/05/2011	EP1841463B1 Methods and compositions for treating, inhibiting and reversing disorders of the intervertebral disc
10/05/2011	EP1749097B1 Replication competent viruses capable of silencing virus inhibitory factor expression
10/05/2011	EP1377680B1 Diagnosis and treatment of breast cancer based upon scn5a
10/05/2011	EP1355676B1 Method of protecting therapeutic compositions from host-mediated inactivation
10/05/2011	EP1267945B1 Genetically modified cells expressing a tgf-beta inhibitor, the cells being lung cancer cells
10/05/2011	EP1246920B1 Prevention of affections associated with porcine circovirus-2
10/05/2011	EP1137777B1 Novel compounds derived from neisseria meningitidis
10/05/2011	EP1017835B1 Cytochrome p450 reductase for the enhancement of p450-based anti-cancer gene therapy
10/05/2011	EP0975762B1 Type-1 ribosome-inactivating protein
10/05/2011	CN1446227B Novel fibroblast growth factor (FRF23) and method for use
10/05/2011	CN102209784A Periostin-induced pancreatic regeneration
10/05/2011	CN102206679A Shuttle vector of vaccinia virus and its application
10/05/2011	CN102206677A Construction and application of overexpression vector of mouse adiponectin gene
10/05/2011	CN102206676A Vector for controlling gender of animals and application thereof
10/05/2011	CN102206663A Nucleic acid construct containing full-length genome of human hepatitis C virus and uses
10/05/2011	CN102206642A Double-stranded RNA molecule with mammal body fluid stability, and preparation method and application thereof
10/05/2011	CN102206633A Improved gene expression
10/05/2011	CN102206613A Acquisition and use of tumor-selective replicative adenovirus - thymidine kinase gene construct
10/05/2011	CN102206275A Anti-tetanotoxin monoclonal neutral antibody, and composition and application thereof
10/05/2011	CN102205134A Chitosan-DNA nanometer granule complex and preparation method thereof
10/05/2011	CN102205133A Preparation method and application of polycation-coated adenovirus composition
10/05/2011	CN102205132A Preparation formula of gene therapy medicament taking recombinant adeno-associated virus (rAAV) as vector

1 ... 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 ... 870